Explore cutting-edge research on PARP inhibitor resistance in this 52-minute scientific symposium presentation delivered by Dr. Jos Jonkers from The Netherlands Cancer Institute and Leiden University at Dana-Farber Cancer Institute's 2023 Center for BRCA and Related Genes Scientific Symposium. Delve into the mechanisms behind PARP inhibitor resistance and discover potential strategies for overcoming these challenges in cancer treatment. Learn about the latest developments in BRCA-related cancer research and their implications for improving therapeutic outcomes in patients receiving PARP inhibitor therapy.
Overview
Syllabus
Understanding and Overcoming PARP Inhibitor Resistance
Taught by
Dana-Farber Cancer Institute
Related Courses
-
De-escalating PARP Inhibitor Maintenance Therapy in Ovarian Cancer Using Adaptive Therapy
-
DDR Deficiency and Replication Stress as Therapeutic Targets for Pancreatic Cancer - 2023
-
Haploinsufficient Phenotypes of BRCA1/2-Mutant Breast Tissue - 2023
-
Synthetic Lethal Interactions of BRCA1 in Stalled-Fork Repair - 2023
-
Health Literacy and Barriers to Engaging People in Clinical Trials - 2023
-
Ecological Niches for the Development of Drug-Induced Resistance
